Novavax's COVID vaccine nears the finish line
The Novavax vaccine appears to be about 90% effective at preventing mild, moderate and severe COVID-19, Food and Drug Administration scientists say in an analysis of the company's data.
A vaccine that may entice some people who have been hesitant to get vaccinated against COVID-19 appears to be highly effective, Food and Drug Administration scientists concluded in documents released Friday.
The vaccine, made by ., of Gaithersburg, Md., was about 90% effective at preventing mild, moderate and severe COVID-19 when tested in a study involving about 30,000 volunteers ages
